Top Health-care stocks:
Health-care shares were generally higher in pre-market trade Wednesday.
In health-care stocks news, Lexicon Pharmaceuticals ( LXRX ) shares climbed in Wednesday's pre-market session after the biopharmaceutical company said it and biopharmaceutical giant Bristol-Myers Squibb ( BMY ) have selected a development candidate for neuropathic pain as part of their alliance on neuroscience drug discovery and development.
Shares in the company were trading 12.1% higher at $1.02 during pre-market trading . Over the past 52 weeks, the company has traded between $0.80 and $1.82.
Meanwhile Galmed Pharmaceuticals ( GLMD ) shares were initiated by Roth Capital with buy rating and $20 price target.
Shares in the company were 3.6% higher at $9.10 during pre-market trading. Over the past 52 weeks, the company has traded between $4.58 and $13.50.
And Navidea Biopharmaceuticals ( NAVB ) Wednesday reported it is scheduled to present data on April 22 at the American Association of Cancer Research (AACR) meeting regarding its therapies to treat Karposi's Sarcoma, a cancer that causes abnormal tissue to grow under the skin, usually in reaction to herpes viruses, and often seen by HIV experts.
Shares in the company were unchanged at $1.52 during pre-market trading. Over the past 52 weeks, the company has traded between $0.97 and $2.02.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.